Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1981 Sep;44(9):786–790. doi: 10.1136/jnnp.44.9.786

Platelet monoamine oxidase activity and headache.

V Glover, R Peatfield, R Zammit-Pace, J Littlewood, M Gawel, F C Rose, M Sandler
PMCID: PMC491137  PMID: 7310418

Abstract

Mean platelet monoamine oxidase activity was reduced compared with control values in groups of headache-free male (but not female) patients suffering from classical migraine and from tension headache. Mean activity in male cluster patients, headache free, both during acute and quiescent phases of their illness, was also notably reduced. Retesting some migraine subjects after up to four years, showed that low activity may be a persistent feature: the correlation coefficient for repeated assays was 0.91 (p less than 0.01). There was no relationship between platelet monoamine oxidase activity and history of dietary migraine. A subgroup of headache patients with permanently low monoamine oxidase activity values may have been defined.

Full text

PDF
786

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anthony M., Hinterberger H., Lance J. W. Plasma serotonin in migraine and stress. Arch Neurol. 1967 May;16(5):544–552. doi: 10.1001/archneur.1967.00470230096013. [DOI] [PubMed] [Google Scholar]
  2. Bussone G., Giovannini P., Boiardi A., Boeri R. A study of the activity of platelet monoamine oxidase in patients with migraine headaches or with 'cluster headaches'. Eur Neurol. 1977;15(3):157–162. doi: 10.1159/000114806. [DOI] [PubMed] [Google Scholar]
  3. Couch J. R., Hassanein R. S. Platelet aggregability in migraine. Neurology. 1977 Sep;27(9):843–848. doi: 10.1212/wnl.27.9.843. [DOI] [PubMed] [Google Scholar]
  4. Deshmukh S. V., Meyer J. S. Cyclic changes in platelet dynamics and the pathogenesis and prophylaxis of migraine. Headache. 1977 Jul;17(3):101–108. doi: 10.1111/j.1526-4610.1977.hed1703101.x. [DOI] [PubMed] [Google Scholar]
  5. Donnelly C. H., Murphy D. L. Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase. Biochem Pharmacol. 1977 May 1;26(9):853–858. doi: 10.1016/0006-2952(77)90398-7. [DOI] [PubMed] [Google Scholar]
  6. Elsworth J. D., Glover V., Sandler M. Tele-Methylhistamine is a specific MAO B substrate in man. Psychopharmacology (Berl) 1980;69(3):287–290. doi: 10.1007/BF00433097. [DOI] [PubMed] [Google Scholar]
  7. Friedhoff A. J., Miller J. C., Karpatkin S. Heterogeneity of human platelets. VII. Platelet monoamine oxidase activity in normals and patients with autoimmune thrombocytopenic purpura and reactive thrombocytosis: its relationship to platelet protein density. Blood. 1978 Feb;51(2):317–323. [PubMed] [Google Scholar]
  8. Gawel M., Burkitt M., Rose F. C. The platelet release reaction during migraine attacks. Headache. 1979 Sep;19(6):323–327. doi: 10.1111/j.1526-4610.1979.hed1906323.x. [DOI] [PubMed] [Google Scholar]
  9. Glover V., Sandler M., Grant E., Rose F. C., Orton D., Wilkinson M., Stevens D. Transitory decrease in platelet monoamine-oxidase activity during migraine attacks. Lancet. 1977 Feb 19;1(8008):391–393. doi: 10.1016/s0140-6736(77)92604-6. [DOI] [PubMed] [Google Scholar]
  10. Hanington E. Letter: Monoamine oxidase and migraine. Lancet. 1974 Nov 9;2(7889):1148–1149. doi: 10.1016/s0140-6736(74)90918-0. [DOI] [PubMed] [Google Scholar]
  11. Hough L. B., Domino E. F. Tele-methylhistamine oxidation by type B monoamine oxidase. J Pharmacol Exp Ther. 1979 Mar;208(3):422–428. [PubMed] [Google Scholar]
  12. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  13. Sandler M. Implications of the platelet monoamine oxidase deficit during migraine attacks. Res Clin Stud Headache. 1978;6:65–72. [PubMed] [Google Scholar]
  14. Sandler M., Reveley M. A., Glover V. Human platelet monoamine oxidase activity in health and disease: a review. J Clin Pathol. 1981 Mar;34(3):292–302. doi: 10.1136/jcp.34.3.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sandler M., Youdim M. B., Hanington E. A phenylethylamine oxidising defect in migraine. Nature. 1974 Jul 26;250(464):335–337. doi: 10.1038/250335a0. [DOI] [PubMed] [Google Scholar]
  16. Sicuteri F., Buffoni F., Anselmi B., Del Bianco P. L. An enzyme (MAO) defect on the platelets in migraine. Res Clin Stud Headache. 1970;3:245–251. [PubMed] [Google Scholar]
  17. VAHLQUIST B. Migraine in children. Int Arch Allergy Appl Immunol. 1955;7(4-6):348–355. doi: 10.1159/000228238. [DOI] [PubMed] [Google Scholar]
  18. Yang H. Y., Neff N. H. Beta-phenylethylamine: a specific substrate for type B monoamine oxidase of brain. J Pharmacol Exp Ther. 1973 Nov;187(2):365–371. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES